Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 3/20 | 0.51 |
| ▸ | QRFPR | Q96P65 | 5/20 | 0.50 |
| ▸ | MME | P08473 | 1/20 | 0.49 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.48 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 1/20 | 0.46 |
| ▸ | MMP2 | P08253 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29591024 | 0.97 | CTSB (0.49) | CTSBQRFPRMMEOPRM1OPRD1 | |
| SCHEMBL29591605 | 0.94 | OPRD1 (0.51) | CTSBQRFPROPRM1OPRD1OPRK1 | |
| SCHEMBL23142823 | 0.92 | CTSB (0.55) | CTSBQRFPRMMEOPRM1OPRD1 | |
| SCHEMBL30051999 | 0.92 | CTSB (0.55) | CTSBQRFPRMMEOPRM1OPRD1 | |
| SCHEMBL23142822 | 0.92 | CTSB (0.55) | CTSBQRFPRMMEOPRM1OPRD1 | |
| SCHEMBL30051480 | 0.92 | CTSB (0.55) | CTSBQRFPRMMEOPRM1OPRD1 | |
| SCHEMBL31514370 | 0.90 | MME (0.53) | MMEALDH1A1RAB9AACEMMP2 | |
| SCHEMBL2032501 | 0.89 | MMP2 (0.56) | MMEACEMMP2ITGB3ITGA2B | |
| SCHEMBL2032499 | 0.89 | MMP2 (0.56) | MMEACEMMP2ITGB3ITGA2B | |
| SCHEMBL16983210 | 0.89 | MMP2 (0.56) | MMEACEMMP2ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |